Grant directory

Open

Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.

Open

Trains dentists as independent researchers through a part-time postdoctoral post.

Open

Funds a novel recording or modulation technology for the human central nervous system from proof of concept up to readiness for first-in-human studies.

Open

Funds three years of stipend support for postdocs training in immunology and cancer research.

Open

Funds non-clinician early-career researchers to run their own cardiovascular project.

Open

Funds postdoctoral cardiovascular researchers for up to 7 years toward full independence.

Open

Funds breakthrough and frontier health and medical research with potential to transform health outcomes.

Open

Funds research where HIV and drug use intersect. Preliminary data are compulsory, and the work must sit on NIH's published HIV priorities.

Open

Funds Canadian investigator infrastructure for flagship science outcomes through national competition.

Open

Funds the implementation of a clinical trial in arthritis, musculoskeletal or skin disease as a phased cooperative agreement with the institute.

Open

Funds NIDDK-led research studying HIV and AIDS comorbidities across metabolic, kidney, and digestive disease.

Open

Funds a translational research project run jointly with NIH's own intramural investigators at the Clinical Center, up to $500,000.

Open

Funds independent Parkinson's disease investigators pursuing bold, high-risk projects with translational clinical relevance.

Open

Supports early Parkinson's disease scientists building translational impact by funding postdoctoral research roles.

Open

Supports early-career neurologists launching Parkinson's disease research careers through postdoctoral fellowship funding.

Open

Funds early-career Parkinson's disease researchers at United States and Canada institutions through independent investigator support.

Open

Funds preclinical testing for novel neural recording and modulation technologies before clinical transition.

Open

Funds UW Madison spin-out research teams to advance commercialization through faculty-led projects.

Open

Awards up to $13.1 million across three phases to US-based teams developing novel technologies that target RNA to treat human disease.

Open

Funds a therapeutic or diagnostic device for the nervous system through prototyping, safety testing, regulatory clearance and a first small clinical study.

Open

Pays up to $120,000 per Interim Milestone winner and up to $320,000 per Final Submission winner to US-based researchers, startups and institutions that build a working prototype technology able to target endogenous RNA in human disease.

Open

Visa-fee reimbursement for eligible international hires at UK scale-ups.

Open

Funds joint research and development projects that pair an organisation from a EUREKA member country with an independent partner in a market outside the network, such as Japan, Taiwan, India or Uruguay.

Open

Awards up to $250,000 in cash and in-kind prizes to Tufts-affiliated founders.